Retraction: miR-1244/Myocyte Enhancer Factor 2D Regulatory Loop Contributes to the Growth of Lung Carcinoma (DNA and Cell Biology 34:11 (692–700) DOI: 10.1089/dna.2015.2915);MiR-1244/Myocyte Enhancer Factor 2D Regulatory Loop Contributes to the Growth of Lung Carcinoma

DNA and Cell Biology

Volumn 34, Issue 11, 2015, Pages 692-700

  Zhang, Rui ^a   Zhang, Yong ^b   Li, He ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b PANZHIHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 1244; MYOCYTE ENHANCER FACTOR 2; MYOCYTE ENHANCER FACTOR 2D; UNCLASSIFIED DRUG; MEF2D PROTEIN, HUMAN; MIRN1244 MICRORNA, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOREGULATION; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LUNG CANCER CELL LINE; LUNG CARCINOMA; LUNG FIBROBLAST; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TUMOR INVASION; TUMOR XENOGRAFT; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CELL MOTION; DRUG EFFECTS; DRUG SCREENING; FIBROBLAST; GENETICS; LUNG NEOPLASMS; METABOLISM; PATHOLOGY; REFERENCE VALUE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MEF2 TRANSCRIPTION FACTORS; MICE, INBRED BALB C; MICRORNAS; REFERENCE VALUES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84946729655     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2015.2915.retract     Document Type: Erratum

References (9)

1. Gao, W., Xu, J., Liu, L., Shen, H., Zeng, H., and Shu, Y. (2012). A systematic-analysis of predicted miR-21 targets identifies a signature for lung cancer. Biomed Pharmacother 66, 21-28.
2. Izumi, K., Zhang, Z., Kaur, M., and Krantz, I. D. (2014). 12p microRNA expression in fibroblast cell lines from probands with Pallister-Killian syndrome. Chromosome Res 22, 453-461.
3. Joshi, P., Middleton, J., Jeon, Y. J., and Garofalo, M. (2014). MicroRNAs in lung cancer. World J Methodol 4, 59-72.
4. Kriebel, S., Schmidt, D., Holdenrieder, S., Goltz, D., Kristiansen, G., Moritz, R., et al. (2015). Analysis of tissue and serum microRNA expression in patients with upper urinary tract urothelial cancer. PLoS One 10, e0117284.
5. Ma, L., Liu, J., Liu, L., Duan, G., Wang, Q., Xu, Y., et al. (2014). Overexpression of the transcription factor MEF2D in hepatocellular carcinoma sustains malignant character by suppressing G2-M transition genes. Cancer Res 74, 1452-1462.
6. Ma, L., Liu, J., Shen, J., Liu, L., Wu, J., Li, W., et al. (2010). Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells. Cancer Biol Ther 9, 554-561.
7. Rutnam, Z. J., and Yang, B. B. (2012). The involvement of microRNAs in malignant transformation. Histol Histopathol 27, 1263-1270.
8. Xue, W., Dahlman, J. E., Tammela, T., Khan, O. F., Sood, S., Dave, A., et al. (2014). Small RNA combination therapy for lung cancer. Proc Natl Acad Sci U S A 111, E3553-E3561.
9. Zhao, X., Liu, M., and Li, D. (2015). Oleanolic acid suppresses the proliferation of lung carcinoma cells by miR-122/cyclin G1/MEF2D axis. Mol Cell Biochem 400, 1-7.